Mannkind Corp
NASDAQ: MNKD
$6.80
-$0.22 (-3.1%)
Closing Price on November 15, 2024
MNKD Articles
These are the top Wall Street analyst upgrades, downgrades and initiations for Wednesday, May 14, 2014. They include Akamai Technologies, Avago Technologies, Pandora Media and Randgold Resources.
Published:
24/7 Wall St. wanted to evaluate the prospects for several would-be blockbuster drugs. Some of these have approvals already in hand, while others have pending FDA approval verdicts.
Published:
While the FDA has been far from a friend to MannKind over the past few years, the latest FDA panel backing may have given diabetes patients and investors some hope. That hope was diminished Monday...
Published:
thinkstockApril 2, 2014: Markets opened mixed on Wednesday following in the ADP payroll data and n increase in factory orders reported early in the day. Mortgage applications were down again as...
Published:
Last Updated:
MannKind has a serious victory within its grasp. The company has struggled to get its Afrezza inhalable insulin to market for years, and that dream now seems to be within its grasp.
Published:
ThinkstockMannKind Corp. (NASDAQ: MNKD)had been trading as though the stock was bracing for an U.S. Food and Drug Administration (FDA) panel decision recommending against the approval of its...
Published:
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on the final day of March 2014. They include BlackBerry, ING, Lululemon, MannKind and Vipshop.
Published:
ThinkstockMannKind Corp. (NASDAQ: MNKD) is a stock that has been on a wild ride for many years. The company’s inhalable insulin has been held up from being approved for years as well. That seems to...
Published:
Piper Jaffray analyst have a list of top biotech stock picks that could bring big gains for investors. The look for high-conviction near-term binary events and lower conviction catalysts with...
Published:
ThinkstockIf you have followed the diabetes drug market for very long, chances are high that you have run across the possibility of an inhalable form of insulin ultimately being approved by the Food...
Published:
Jon OggInterest rates have risen and volatility in stocks has resumed. Traders and investors are looking for bargain stocks but also trying to decide which stocks they should get out as well. These...
Published:
August 16, 2013: U.S. equity markets opened lower this morning following big down day on Thursday. In the U.S., the Census Bureau’s report on July housing starts put up a positive number, while...
Published:
Last Updated:
These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Friday, June 7, 2013. They include Bank of America, J.P. Morgan, Intel, Sprint and Isle of Capri...
Published:
Last Updated:
U.S. equity markets opened sharply lower again this morning, but this time reacting to yesterday’s comments by Fed Chairman Ben Bernanke that the Fed could slow its bond purchases in the next few...
Published:
Last Updated:
U.S. equity markets opened sharply lower this morning, taking a lead from Japan’s Nikkei, which fell more than 7% for the day. Japan’s government bond yields spiked until the Bank of Japan...
Published:
Last Updated: